-
Nirmatrelvir
Zita reAPI Indication Innovator Patent Expiry Date (The US) Nirmatrelvir 3C-Senge Protease (3CLPRO) Inhibitor uye SARS-Cov-2 Mpro Inhibitor -
Niraparib 1038915-60-4
Zita reAPI Indication Innovator Patent Expiry Date (The US) Niraparib 1038915-60-4 Ovarian/Fallopian,chubhu/primary peritoneal cancer Tesaro Ndira 8, 2028